Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.
暂无分享,去创建一个
D. Kent | G. Sledge | B. Ky | R. Ruthazer | S. Parsons | K. Miller | J. Erban | L. Wagner | A. O'neill | B. Demissei | J. Upshaw